$309.63
1.57% yesterday
Nasdaq, Aug 12, 10:00 pm CET
ISIN
US45784P1012
Symbol
PODD

Insulet Corporation Stock price

$309.63
+17.62 6.03% 1M
+30.08 10.76% 6M
+48.56 18.60% YTD
+121.58 64.65% 1Y
+38.93 14.38% 3Y
+104.98 51.30% 5Y
+275.56 808.81% 10Y
+293.67 1,840.04% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+4.79 1.57%

Key metrics

Basic
Market capitalization
$21.5b
Enterprise Value
$22.0b
Net debt
$539.6m
Cash
$1.2b
Shares outstanding
70.4m
Valuation (TTM | estimate)
P/E
56.2 | 69.0
P/S
9.8 | 8.3
EV/Sales
10.0 | 8.5
EV/FCF
78.3
P/B
16.1
Financial Health
Equity Ratio
39.2%
Return on Equity
34.5%
ROCE
11.4%
ROIC
-
Debt/Equity
1.3
Financials (TTM | estimate)
Revenue
$2.2b | $2.6b
EBITDA
$424.5m | $569.1m
EBIT
$340.8m | $425.8m
Net Income
$402.2m | $311.0m
Free Cash Flow
$280.8m
Growth (TTM | estimate)
Revenue
23.5% | 24.5%
EBITDA
31.2% | 46.0%
EBIT
36.8% | 37.8%
Net Income
71.9% | -25.7%
Free Cash Flow
105.4%
Margin (TTM | estimate)
Gross
70.4%
EBITDA
19.3% | 22.1%
EBIT
15.5%
Net
18.3% | 12.1%
Free Cash Flow
12.8%
More
EPS
$5.4
FCF per Share
$4.0
Short interest
4.6%
Employees
4k
Rev per Employee
$530.0k
Show more

Is Insulet Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Insulet Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

32 Analysts have issued a Insulet Corporation forecast:

27x Buy
84%
5x Hold
16%

Analyst Opinions

32 Analysts have issued a Insulet Corporation forecast:

Buy
84%
Hold
16%

Financial data from Insulet Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,199 2,199
23% 23%
100%
- Direct Costs 651 651
17% 17%
30%
1,548 1,548
26% 26%
70%
- Selling and Administrative Expenses 978 978
27% 27%
44%
- Research and Development Expense 229 229
12% 12%
10%
425 425
31% 31%
19%
- Depreciation and Amortization 84 84
13% 13%
4%
EBIT (Operating Income) EBIT 341 341
37% 37%
15%
Net Profit 402 402
72% 72%
18%

In millions USD.

Don't miss a Thing! We will send you all news about Insulet Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Insulet Corporation Stock News

Neutral
Seeking Alpha
5 days ago
Insulet Corporation (NASDAQ:PODD ) Q2 2025 Earnings Call August 7, 2025 8:00 AM ET Company Participants Ana Maria Chadwick - Executive VP & CFO Ashley A. McEvoy - CEO, President & Director Eric Benjamin - Executive VP, Chief Product & Customer Experience Officer June Lazaroff - Senior Director of Investor Relations Conference Call Participants Danielle Joy Antalffy - UBS Investment Bank, Resear...
Positive
The Motley Fool
5 days ago
Insulet (PODD 9.87%), a medical device company specializing in wearable insulin delivery systems, released its second quarter 2025 earnings on August 7, 2025. The headline news was strong outperformance: GAAP revenue rose to $649.1 million, beating estimates by nearly $35 million, while Adjusted earnings per share (EPS) (non-GAAP) topped analyst forecasts by $0.25.
Positive
Investors Business Daily
5 days ago
Insulet stock surged Thursday after the insulin pump-maker walloped second-quarter forecasts and raised its sales guidance for the year.
More Insulet Corporation News

Company Profile

Insulet Corp. is a medical device company. The firm engages in the development, manufacture and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Head office United States
CEO Ashley McEvoy
Employees 3,900
Founded 2000
Website www.omnipod.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today